CLCA3_HUMAN
ID CLCA3_HUMAN Reviewed; 262 AA.
AC Q9Y6N3;
DT 02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1999, sequence version 1.
DT 03-AUG-2022, entry version 110.
DE RecName: Full=Calcium-activated chloride channel regulator family member 3;
DE Short=Calcium-activated chloride channel family member 3;
DE Short=hCLCA3;
DE Flags: Precursor;
GN Name=CLCA3P; Synonyms=CLCA3;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, GLYCOSYLATION, AND TISSUE
RP SPECIFICITY.
RC TISSUE=Spleen;
RX PubMed=10095065; DOI=10.1016/s0167-4781(99)00008-1;
RA Gruber A.D., Pauli B.U.;
RT "Molecular cloning and biochemical characterization of a truncated,
RT secreted member of the human family of Ca2+-activated Cl- channels.";
RL Biochim. Biophys. Acta 1444:418-423(1999).
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10095065}.
CC -!- TISSUE SPECIFICITY: Expressed in the lung, trachea, spleen, thymus and
CC mammary gland. {ECO:0000269|PubMed:10095065}.
CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10095065}.
CC -!- SIMILARITY: Belongs to the CLCR family. {ECO:0000305}.
CC -!- CAUTION: In contrast to other members of the family, this protein is
CC much shorter and lacks the VWFA domain. Defined as a pseudogene by
CC HGNC. PubMed:10095065 reports that it is expressed and glycosylated in
CC mammalian cells. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF043976; AAD23734.1; -; mRNA.
DR AlphaFoldDB; Q9Y6N3; -.
DR ChEMBL; CHEMBL2364708; -.
DR TCDB; 1.A.13.1.4; the epithelial chloride channel (e-clc) family.
DR GlyGen; Q9Y6N3; 2 sites.
DR iPTMnet; Q9Y6N3; -.
DR PhosphoSitePlus; Q9Y6N3; -.
DR BioMuta; HGNC:2017; -.
DR DMDM; 74721541; -.
DR PRIDE; Q9Y6N3; -.
DR GeneCards; CLCA3P; -.
DR HGNC; HGNC:2017; CLCA3P.
DR MIM; 604337; gene.
DR neXtProt; NX_Q9Y6N3; -.
DR InParanoid; Q9Y6N3; -.
DR PhylomeDB; Q9Y6N3; -.
DR PathwayCommons; Q9Y6N3; -.
DR Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR Pharos; Q9Y6N3; Tdark.
DR PRO; PR:Q9Y6N3; -.
DR Proteomes; UP000005640; Unplaced.
DR RNAct; Q9Y6N3; protein.
DR GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR GO; GO:0004222; F:metalloendopeptidase activity; TAS:Reactome.
DR GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR InterPro; IPR013642; CLCA_N.
DR Pfam; PF08434; CLCA; 1.
PE 1: Evidence at protein level;
KW Calcium; Calcium channel; Calcium transport; Chloride; Chloride channel;
KW Glycoprotein; Ion channel; Ion transport; Reference proteome; Secreted;
KW Signal; Transport; Voltage-gated channel.
FT SIGNAL 1..20
FT /evidence="ECO:0000255"
FT CHAIN 21..262
FT /note="Calcium-activated chloride channel regulator family
FT member 3"
FT /id="PRO_0000306400"
FT REGION 45..199
FT /note="Metalloprotease domain; probably inactive"
FT /evidence="ECO:0000250|UniProtKB:A8K7I4"
FT CARBOHYD 75
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 180
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT VARIANT 84
FT /note="Y -> T (requires 2 nucleotide substitutions;
FT dbSNP:rs2292830)"
FT /id="VAR_035296"
FT VARIANT 104
FT /note="I -> T (in dbSNP:rs2292829)"
FT /id="VAR_035297"
SQ SEQUENCE 262 AA; 29971 MW; D6C0E9F21300E33A CRC64;
MVFSLKVILF LSLLLSPVLK SSLVTLNNNG YDGIVIAINP SVPEDEKLIQ NIKEMVTEAS
THLFHATKQR AYFRNVSILI PMTYKSKSEY LIPKQETYDQ ADVIVADLYL KYGDDPYTLQ
YGQCGDKGQY IHFTPNFLLT NNLATYGPRG KVFVHGWAHL RWGVFDEYNV DQPFYISRRN
TTEATRCSTR ITVYMVLNEC KGASCIARPF RRDSQTGLYE AKCTFIPKRS QTAKESIVFM
QNLDSVTEFC TEKTHNKEAP NL